Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury

A critical literature review

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Despite the frequency and morbidity of venous thromboembolism (VTE) development after traumatic brain injury (TBI), no national standard of care exists to guide TBI caregivers for the use of prophylactic anticoagulation. Fears of iatrogenic propagation of intracranial hemorrhage patterns have led to a dearth of research in this field, and it is only relatively recently that studies dedicated to this question have been performed. These have generally been limited to retrospective and/or observational studies in which patients are classified in a binary fashion as having the presence or absence of intracranial blood. This methodology does not account for the fact that smaller injury patterns stabilize more rapidly, and thus may be able to safely tolerate earlier initiation of prophylactic anticoagulation than larger injury patterns. This review seeks to critically assess the literature on this question by examining the existing evidence on the safety and efficacy of pharmacologic VTE prophylaxis in the setting of elective craniotomy (as this is the closest model available from which to extrapolate) and after TBI. In doing so, we critique studies that approach TBI as a homogenous or a heterogenous study population. Finally, we propose our own theoretical protocol which stratifies patients into low, moderate, and high risk for the likelihood of natural progression of their hemorrhage pattern, and which allows one to tailor a unique VTE prophylaxis regimen to each individual arm.

Original languageEnglish (US)
Pages (from-to)1821-1828
Number of pages8
JournalJournal of Neurotrauma
Volume29
Issue number10
DOIs
StatePublished - Jul 1 2012

Fingerprint

Venous Thromboembolism
Intracranial Hemorrhages
Craniotomy
Wounds and Injuries
Standard of Care
Caregivers
Fear
Observational Studies
Retrospective Studies
Hemorrhage
Morbidity
Safety
Traumatic Brain Injury
Research
Population

Keywords

  • anticoagulant
  • prophylaxis
  • review
  • traumatic brain injury
  • venous thromboembolism

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury : A critical literature review. / Phelan, Herb A.

In: Journal of Neurotrauma, Vol. 29, No. 10, 01.07.2012, p. 1821-1828.

Research output: Contribution to journalArticle

@article{9de87ef2094d4259b5e1803cadb31531,
title = "Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury: A critical literature review",
abstract = "Despite the frequency and morbidity of venous thromboembolism (VTE) development after traumatic brain injury (TBI), no national standard of care exists to guide TBI caregivers for the use of prophylactic anticoagulation. Fears of iatrogenic propagation of intracranial hemorrhage patterns have led to a dearth of research in this field, and it is only relatively recently that studies dedicated to this question have been performed. These have generally been limited to retrospective and/or observational studies in which patients are classified in a binary fashion as having the presence or absence of intracranial blood. This methodology does not account for the fact that smaller injury patterns stabilize more rapidly, and thus may be able to safely tolerate earlier initiation of prophylactic anticoagulation than larger injury patterns. This review seeks to critically assess the literature on this question by examining the existing evidence on the safety and efficacy of pharmacologic VTE prophylaxis in the setting of elective craniotomy (as this is the closest model available from which to extrapolate) and after TBI. In doing so, we critique studies that approach TBI as a homogenous or a heterogenous study population. Finally, we propose our own theoretical protocol which stratifies patients into low, moderate, and high risk for the likelihood of natural progression of their hemorrhage pattern, and which allows one to tailor a unique VTE prophylaxis regimen to each individual arm.",
keywords = "anticoagulant, prophylaxis, review, traumatic brain injury, venous thromboembolism",
author = "Phelan, {Herb A.}",
year = "2012",
month = "7",
day = "1",
doi = "10.1089/neu.2012.2459",
language = "English (US)",
volume = "29",
pages = "1821--1828",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury

T2 - A critical literature review

AU - Phelan, Herb A.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Despite the frequency and morbidity of venous thromboembolism (VTE) development after traumatic brain injury (TBI), no national standard of care exists to guide TBI caregivers for the use of prophylactic anticoagulation. Fears of iatrogenic propagation of intracranial hemorrhage patterns have led to a dearth of research in this field, and it is only relatively recently that studies dedicated to this question have been performed. These have generally been limited to retrospective and/or observational studies in which patients are classified in a binary fashion as having the presence or absence of intracranial blood. This methodology does not account for the fact that smaller injury patterns stabilize more rapidly, and thus may be able to safely tolerate earlier initiation of prophylactic anticoagulation than larger injury patterns. This review seeks to critically assess the literature on this question by examining the existing evidence on the safety and efficacy of pharmacologic VTE prophylaxis in the setting of elective craniotomy (as this is the closest model available from which to extrapolate) and after TBI. In doing so, we critique studies that approach TBI as a homogenous or a heterogenous study population. Finally, we propose our own theoretical protocol which stratifies patients into low, moderate, and high risk for the likelihood of natural progression of their hemorrhage pattern, and which allows one to tailor a unique VTE prophylaxis regimen to each individual arm.

AB - Despite the frequency and morbidity of venous thromboembolism (VTE) development after traumatic brain injury (TBI), no national standard of care exists to guide TBI caregivers for the use of prophylactic anticoagulation. Fears of iatrogenic propagation of intracranial hemorrhage patterns have led to a dearth of research in this field, and it is only relatively recently that studies dedicated to this question have been performed. These have generally been limited to retrospective and/or observational studies in which patients are classified in a binary fashion as having the presence or absence of intracranial blood. This methodology does not account for the fact that smaller injury patterns stabilize more rapidly, and thus may be able to safely tolerate earlier initiation of prophylactic anticoagulation than larger injury patterns. This review seeks to critically assess the literature on this question by examining the existing evidence on the safety and efficacy of pharmacologic VTE prophylaxis in the setting of elective craniotomy (as this is the closest model available from which to extrapolate) and after TBI. In doing so, we critique studies that approach TBI as a homogenous or a heterogenous study population. Finally, we propose our own theoretical protocol which stratifies patients into low, moderate, and high risk for the likelihood of natural progression of their hemorrhage pattern, and which allows one to tailor a unique VTE prophylaxis regimen to each individual arm.

KW - anticoagulant

KW - prophylaxis

KW - review

KW - traumatic brain injury

KW - venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84863808541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863808541&partnerID=8YFLogxK

U2 - 10.1089/neu.2012.2459

DO - 10.1089/neu.2012.2459

M3 - Article

VL - 29

SP - 1821

EP - 1828

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 10

ER -